Table_1.xls (13.5 kB)
HIV-1 seropositive subjects under HAART treatment used for ‘Opal-HIV-Gag(c)’ vaccine administration.
dataset
posted on 2013-10-04, 01:48 authored by Henrik N. Kløverpris, Akil Jackson, Amanda Handley, Peter Hayes, Jill Gilmour, Lynn Riddell, Fabian Chen, Mark Atkins, Marta Boffito, Bruce D. Walker, Jim Ackland, Mark Sullivan, Philip Gouldera
Values obtained at baseline defined as day of first vaccination.
bWithdrawn from study after two administrations (014) or after one administration (019 and 024).
